Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Patrick M Honore, David De Bels, Herbert D Spapen

Research output: Contribution to journalEditorial

Original languageEnglish
Article number96
Pages (from-to)96-96
Number of pages1
JournalAnnals of Intensive Care
Issue number1
Publication statusPublished - 27 Sep 2018


  • Antioxidant therapy
  • Astragaloside IV
  • Crush syndrome
  • Ischemia–reperfusion injury
  • Rhabdomyolysis

Cite this